Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02478320
Title Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

Advanced Solid Tumor

Therapies

ABT-348

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST